Clinical Trial Update: Exacerbations Among Patients Receiving Breztri (EROS Study)

View source ↗

Summary

This clinical trial update reports on exacerbation outcomes in patients with chronic obstructive pulmonary disease treated with Breztri (budesonide/glycopyrroni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Breztri (budesonide/glycopyrronium/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED